NZ509031A - A disk formed from a filmogenic polymer carrying a therapeutic agent selected from a stabiliser, a solubiliser, an enhancer and a plasticiser - Google Patents

A disk formed from a filmogenic polymer carrying a therapeutic agent selected from a stabiliser, a solubiliser, an enhancer and a plasticiser

Info

Publication number
NZ509031A
NZ509031A NZ509031A NZ50903199A NZ509031A NZ 509031 A NZ509031 A NZ 509031A NZ 509031 A NZ509031 A NZ 509031A NZ 50903199 A NZ50903199 A NZ 50903199A NZ 509031 A NZ509031 A NZ 509031A
Authority
NZ
New Zealand
Prior art keywords
therapeutic agent
enhancer
solubiliser
plasticiser
stabiliser
Prior art date
Application number
NZ509031A
Other languages
English (en)
Inventor
Spiros Fotinos
Original Assignee
Lavipharm Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22223792&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NZ509031(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lavipharm Lab Inc filed Critical Lavipharm Lab Inc
Publication of NZ509031A publication Critical patent/NZ509031A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices ; Anti-rape devices
    • A61F5/41—Devices for promoting penis erection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Nursing (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Attitude Control For Articles On Conveyors (AREA)
NZ509031A 1998-06-25 1999-06-25 A disk formed from a filmogenic polymer carrying a therapeutic agent selected from a stabiliser, a solubiliser, an enhancer and a plasticiser NZ509031A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9067498P 1998-06-25 1998-06-25
PCT/US1999/014410 WO1999066870A1 (en) 1998-06-25 1999-06-25 A device and method for the treatment of erectile dysfunction

Publications (1)

Publication Number Publication Date
NZ509031A true NZ509031A (en) 2002-10-25

Family

ID=22223792

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ509031A NZ509031A (en) 1998-06-25 1999-06-25 A disk formed from a filmogenic polymer carrying a therapeutic agent selected from a stabiliser, a solubiliser, an enhancer and a plasticiser

Country Status (11)

Country Link
EP (1) EP1089679B1 (https=)
JP (1) JP2002518417A (https=)
AT (1) ATE303774T1 (https=)
AU (1) AU765057B2 (https=)
CA (1) CA2335736A1 (https=)
DE (1) DE69927154T2 (https=)
HU (1) HUP0103206A3 (https=)
IL (2) IL140475A0 (https=)
NZ (1) NZ509031A (https=)
PL (1) PL345087A1 (https=)
WO (1) WO1999066870A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6552024B1 (en) * 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
AU5907300A (en) 1999-07-02 2001-01-22 Procter & Gamble Company, The Compositions comprising organosiloxane resins for delivering xylitol to the oralcavity
KR100402334B1 (ko) 2000-06-23 2003-10-22 환인제약 주식회사 알프로스타딜 외용제
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
WO2002017927A1 (en) * 2000-08-30 2002-03-07 Unimed Pharmaceuticals, Inc. Method for treating erectile dysfunction and increasing libido in men
US6899897B2 (en) * 2001-06-18 2005-05-31 Jaleva, Inc. Gum resin as a carrier for topical application of pharmacologically active agents
US8524200B2 (en) 2002-09-11 2013-09-03 The Procter & Gamble Company Tooth whitening products
US20050181030A1 (en) * 2003-01-03 2005-08-18 Mo Y. J. Topical stabilized prostaglandin E compound dosage forms
US6841574B2 (en) * 2003-01-03 2005-01-11 Nexmed Holdings, Inc. Topical stabilized prostaglandin E compound dosage forms
MXPA05008142A (es) 2003-01-31 2005-09-30 Sankyo Co Medicamento para la profilaxis y el tratamiento de arteriosclerosis e hipertension.
JP4157889B2 (ja) * 2003-06-25 2008-10-01 有限会社 循環器研究所 性交機能改善用外用製剤
US9554984B2 (en) 2003-11-03 2017-01-31 Jaleva Pharmaceuticals, Llc Oral care compositions for topical application
CA2629810A1 (en) 2005-11-07 2007-05-18 Jaleva, Llc Film-forming resins as a carrier for topical application of pharmacologically active agents
IT201600119871A1 (it) * 2016-11-25 2018-05-25 Sabatino Russo Uso dell’associazione di inibitori della fosfodiesterasi 5 con prostaglandina e1 per il trattamento della disfunzione erettile

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4725439A (en) * 1984-06-29 1988-02-16 Alza Corporation Transdermal drug delivery device
JPS61204117A (ja) * 1985-03-07 1986-09-10 Tooa Eiyoo Kk 経皮吸収外用剤
FI872552L (fi) 1986-06-09 1987-12-10 American Cyanamid Co Prostaglandinkomposition foer lokalt bruk.
EP0266968A3 (en) * 1986-11-03 1988-08-24 Gérard G. Cohen Gelled ointment of vasodilating agent
US4829991A (en) * 1987-01-06 1989-05-16 Medical Engineering Corp. Method and device for stimulating an erection
SU1705319A1 (ru) * 1987-10-23 1992-01-15 Всесоюзный Научно-Исследовательский Институт Биотехнологии Состав полимерной диффузионной матрицы дл трансдермального введени лекарственных веществ
US5242391A (en) 1990-04-25 1993-09-07 Alza Corporation Urethral insert for treatment of erectile dysfunction
IT1247678B (it) 1990-05-31 1994-12-28 Alberto Reale Metodo per la cura dell'impotenza erettiva maschile
US5202125A (en) * 1990-12-10 1993-04-13 Theratech, Inc. Method and systems for administering nitroglycerin transdermally at enhanced transdermal fluxes
DE4117249C2 (de) 1991-05-27 1998-05-14 Christian Dr Stief Linsidomin zur Behandlung erektiler Dysfunktionen
AU669492B2 (en) * 1991-11-11 1996-06-13 Hisamitsu Pharmaceutical Co., Inc. Fomentation containing ketorolac
DE69326848T2 (de) * 1992-05-13 2000-01-27 Alza Corp Oxybutynin zur transdermalen Verabreichung
US6007836A (en) * 1993-05-28 1999-12-28 Vericade, Inc. Transdermal vasodilator
CA2161974A1 (en) * 1993-05-28 1994-12-08 Eric L. Denzer Condom with transdermal vasodilator
US5333621A (en) * 1993-05-28 1994-08-02 Eric Denzer Condom with transdermal vasodilator
GB9311920D0 (en) 1993-06-09 1993-07-28 Pfizer Ltd Therapeutic agents
PT742011E (pt) * 1994-11-17 2002-10-31 Toray Industries Preparacao que pode ser absorvida por via percutanea
FR2729296B1 (fr) * 1995-01-12 1997-03-28 Europlanaire Compositions pharmaceutiques comprenant une superoxyde dismutase
US5741511A (en) * 1995-04-12 1998-04-21 Sam Yang Co., Ltd. Transdermal drug delivery device for treating erectile dysfunction
FR2748658B1 (fr) * 1996-05-15 2000-08-18 Biotec Centre Sa Utilisation de composes du type "alpha-bloquants" notamment le moxisylyte et/ou ses derives pour le traitement de dysfonctionnements erectiles par voie transmucosale balanique
WO1998017315A2 (en) * 1996-10-24 1998-04-30 Alza Corporation Permeation enhancers for transdermal drug delivery compositions, devices, and methods

Also Published As

Publication number Publication date
HUP0103206A2 (hu) 2002-05-29
WO1999066870A1 (en) 1999-12-29
EP1089679B1 (en) 2005-09-07
IL140475A (en) 2007-05-15
CA2335736A1 (en) 1999-12-29
EP1089679A1 (en) 2001-04-11
DE69927154D1 (de) 2005-10-13
ATE303774T1 (de) 2005-09-15
IL140475A0 (en) 2002-02-10
AU4720099A (en) 2000-01-10
DE69927154T2 (de) 2006-06-29
AU765057B2 (en) 2003-09-04
JP2002518417A (ja) 2002-06-25
PL345087A1 (en) 2001-12-03
HUP0103206A3 (en) 2002-11-28

Similar Documents

Publication Publication Date Title
JP4619894B2 (ja) 粘膜表面への、薬剤化合物の送達に適する薬剤キャリアデバイス
NZ509031A (en) A disk formed from a filmogenic polymer carrying a therapeutic agent selected from a stabiliser, a solubiliser, an enhancer and a plasticiser
IL135258A0 (en) Bioadhesive compositions and methods for topical administration of active agents
US6103266A (en) Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues
BR0308137A (pt) Formulações de droga de liberação constante contendo um peptìdeo veìculo
DE60021059D1 (de) Hydrogelpartikel formulierungen
AR012854A1 (es) Una composicion de suministro de droga para la liberacion controlada de un ingrediente activo en el ambiente estomacal por un periodo de tiempoprolongado, una composicion farmaceutica que la comprende, el uso de dicha composicion en la fabricacion de un medicamento, un proceso para la preparacion
EP1125577A3 (en) Liquid drug delivery compositions
HUP9904174A2 (hu) Bőrön át történő adagoláshoz szánt gyógyszerkészítmények
PT957900E (pt) Composicoes e metodos para aplicacao topica de agentes terapeuticos
BR9913154A (pt) Composição de musse
WO2002015877A8 (en) Methods and compositions for targeted delivery
WO2001072281A3 (en) Microspheres for active embolization
BR9808888A (pt) Formas de dosagem e método de melhorar disfunção erétil masculina
FI913410A0 (fi) Kontinuerligt frigoerande farmaceutiska kompositioner.
CA2027053A1 (en) Estrogen-Containing Active Substance Plaster
HUP0003405A2 (hu) Szabályozott hatóanyag-leadású, szublingvális vagy bukkális adagolású gyógyszerkészítmények
ATE202926T1 (de) Pharmazeutische brausepräparate enthaltend bioabbaubare mikrokapseln zur kontrolierten wirkstofffreisetzung
BRPI0406858A (pt) Liberação controlada de agentes altamente solúveis
WO2007022090A3 (en) Topical delivery with a carrier fluid
CO5640120A2 (es) Formulacion y metodods para el tratamiento de trombocitemia
PA8615501A1 (es) Formulaciones farmaceuticas transdermicas
KR20170032801A (ko) 아토피 피부염 치료제 전달을 위한 용해성 미세바늘 패치
KR20170046043A (ko) 백반증 치료제 전달을 위한 용해성 미세바늘 패치
AR024199A1 (es) Uso de la buprenorfina en la preparacion de un disposotivo de suministro transdermico

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)